|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.72 USD | +4.30% |
|
-1.61% | +13.16% |
| 21/07 | Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 | RE |
| 08/07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 57.94 | 57.94 | 56.71 |
| Spread/Res. | -13.97% | -13.97% | -12.11% |
| Spread/Supp. | +5.20% | +5.20% | +24.58% |
| Support | 47.38 | 47.38 | 40.01 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
Select your edition
All financial news and data tailored to specific country editions
